Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 4,735.00
+365.00 (8.35%)
At close: Jul 31, 2026
Pharos iBio Market Cap
Pharos iBio has a market cap or net worth of 61.3 billion as of July 31, 2026. Its market cap has decreased by -19.61% in one year.
Market Cap
61.30B
Enterprise Value
45.96B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4,735.00
ChartMarket Cap Chart
Since July 27, 2023, Pharos iBio's market cap has decreased from 112.78B to 61.30B, a decrease of -45.65%. That is a compound annual growth rate of -18.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 61.30B | -49.57% |
| Dec 30, 2025 | 121.56B | 24.04% |
| Dec 30, 2024 | 98.00B | -48.85% |
| Dec 28, 2023 | 191.59B | 69.87% |
| Jul 27, 2023 | 112.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sam-A Pharm. | 74.52B |
| Hwail Pharmaceutical | 73.57B |
| Polaris AI Pharma | 68.41B |
| Optipharm.CO.,LTD | 67.70B |
| GL Pharm Tech | 63.12B |
| Sinsin Pharmaceutical | 62.81B |
| BL Pharmtech | 61.68B |
| Sinil Pharmaceutical | 57.56B |